503A vs. 503B Compounding Pharmacies: What Patients Need to Know
If you've been prescribed a compounded medication, you may have seen "503A" or "503B" on your prescription label — or heard these terms from your provider. Most patients have no idea what they mean. This plain-language guide explains what each category refers to and how they differ in oversight and scale.
† This article is for educational purposes only. It does not constitute medical or legal advice, and it does not describe what any particular pharmacy or medication is permitted to do. Compounding regulations are complex and subject to change. Consult your licensed healthcare provider with questions about your treatment, and refer to the FDA's published guidance for current regulatory information.
Key takeaways
503A pharmacies are state-licensed and compound against individual patient prescriptions. They are overseen by state pharmacy boards.
503B outsourcing facilities are registered with the FDA, may produce in bulk, and are subject to FDA inspections and cGMP requirements.
Neither category produces FDA-approved drugs. Compounded medications are not reviewed by the FDA for safety, effectiveness, or manufacturing quality.
The 503A/503B distinction describes facility oversight and production scale — not the approval status of any medication.
When evaluating any pharmacy, it's reasonable to ask about state licensure, LegitScript status, sterile compounding standards, and prescription requirements.
What is a compounding pharmacy?
A compounding pharmacy prepares medications for individual patients rather than mass-producing standardized drugs. Compounding has a long history in medicine — it was the primary way medications were prepared before industrial pharmaceutical manufacturing.
Today, compounding is used when a patient needs a dose, formulation, or ingredient combination that a commercially manufactured product does not provide. Whether compounding is appropriate in any individual case is a clinical determination made by a licensed prescribing provider.
Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act), compounding operations fall into two distinct categories with different regulatory frameworks. Understanding the difference helps you ask better questions about your own prescription.
503A — patient-specific compounding pharmacies
What 503A refers to
503A describes state-licensed compounding pharmacies that prepare medications based on individual patient prescriptions. This is the traditional model of compounding: one prescription, one patient, prepared to order.
General characteristics
Licensed and overseen by state pharmacy boards rather than directly by the FDA. Generally expected to follow USP 797 sterile compounding standards when preparing injectable medications. Compound against a valid, patient-specific prescription from a licensed provider. Typically operate at smaller scale than 503B outsourcing facilities. Interstate dispensing is governed by state licensure and applicable regulations.
503B — FDA-registered outsourcing facilities
What 503B refers to
503B describes outsourcing facilities that register with the FDA. Unlike 503A pharmacies, outsourcing facilities may produce medications in larger batches without an individual prescription for each patient, typically for distribution to healthcare facilities.
General characteristics
Registered with and inspected by the FDA. Generally subject to federal Current Good Manufacturing Practice (cGMP) requirements. May produce larger batches without individual prescriptions. Subject to FDA facility inspections. Operate at higher production scale than 503A pharmacies.
An important clarification
Registration with the FDA is not the same as FDA approval of a medication. A 503B facility being federally registered and inspected does not mean the medications it compounds have been reviewed by the FDA for safety, effectiveness, or manufacturing quality. They have not.
Side-by-side comparison
Neither 503A nor 503B compounded medications are FDA-approved. The distinction concerns facility oversight and production scale — not the approval status of the medication itself. This table is a general summary and not a statement of what any specific facility is permitted to do.
Questions worth asking about any compounding pharmacy
Whatever medication you're prescribed, these are reasonable things to ask your provider or the dispensing pharmacy.
Is the pharmacy licensed in my state?
Most state pharmacy boards publish an online license lookup tool where you can verify a pharmacy's licensure status directly.
Is the pharmacy LegitScript certified?
LegitScript is an independent verification program. Certification status can be checked directly through LegitScript rather than taken on a pharmacy's word.
Does the pharmacy follow USP 797 sterile compounding standards?
USP 797 sets standards for preparing sterile medications, including injectables. Your provider or pharmacy should be able to answer this.
Is a valid prescription required?
Compounded medications are prescription medications. A pharmacy that does not require a prescription from a licensed provider is not a pharmacy you should be using.
Is there a verifiable U.S. address and phone number?
Be cautious of operations with no physical location or only a web contact form.
Frequently asked questions
What is a 503A compounding pharmacy?
A 503A compounding pharmacy is a state-licensed pharmacy that prepares medications based on individual patient prescriptions. It is overseen by state pharmacy boards and generally follows USP 797 standards when preparing sterile injectable medications.
What is a 503B compounding pharmacy?
A 503B outsourcing facility is a compounding operation registered with the FDA. Outsourcing facilities may produce medications in larger batches without individual prescriptions, are generally subject to cGMP requirements, and are subject to FDA facility inspections.
Are compounded medications FDA-approved?
No. Compounded medications from both 503A and 503B pharmacies are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or manufacturing quality. The 503A/503B distinction concerns facility oversight and production scale, not approval of the medication.
Does FDA registration mean a 503B facility's medications are FDA-approved?
No. Facility registration and inspection are not the same as approval of a medication. Medications compounded by a 503B outsourcing facility are not FDA-approved.
What should I look for in a compounding pharmacy?
Consider checking state pharmacy board licensure, LegitScript certification status, whether the pharmacy follows USP 797 sterile compounding standards, whether a valid prescription from a licensed provider is required, and whether there is a verifiable U.S. address and phone number. Your provider can answer questions about the pharmacy dispensing your prescription.
† This article is for educational purposes only and does not constitute medical or legal advice. It describes general regulatory categories and is not a statement about what any specific pharmacy, facility, or medication is permitted to do. Compounding regulations are complex and subject to change; refer to the FDA's published guidance for current information. Always consult a qualified, licensed healthcare provider before starting, stopping, or changing any treatment. Compounded medications available through Ondra Health are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or manufacturing quality.